916 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Recruiting Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Genital Diseases, Male;   Prostatic Diseases
Intervention: Drug: EPI-506
3 Not yet recruiting A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
4 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
5 Recruiting Molecular Studies and Clinical Correlations in Human Prostatic Disease
Condition: Prostate Cancer
Intervention:
6 Recruiting A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study
Condition: Castration-Resistant Prostate Cancer
Intervention: Drug: Apalutamide
7 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
8 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
Intervention:
9 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
10 Recruiting Reducing Dexamethasone Around Docetaxel Infusion
Conditions: Breast Cancer;   Prostate Cancer
Interventions: Drug: Dexamethasone;   Drug: Prednisone
11 Recruiting AASUR in High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: ARN-509;   Drug: Abiraterone;   Drug: Leuprolide;   Radiation: stereotactic, ultra-fractionated radiotherapy
12 Not yet recruiting Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy
Condition: Prostatic Neoplasms
Intervention: Biological: PROSTVAC-V/F
13 Recruiting Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA Levels
Condition: Prostatic Neoplasms
Intervention: Other: blood draw
14 Not yet recruiting ARN-509 and Leuprolide in Intermediate and High-risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Leuprolide acetate;   Drug: ARN-509;   Procedure: Radical prostatectomy
15 Recruiting Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Condition: Prostate Cancer
Interventions: Biological: aglatimagene besadenovec;   Biological: placebo;   Drug: valacyclovir
16 Not yet recruiting sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer
Conditions: Infiltrating Bladder Urothelial Carcinoma;   Recurrent Bladder Carcinoma;   Stage I Prostate Cancer;   Stage I Renal Cell Cancer;   Stage II Bladder Urothelial Carcinoma;   Stage II Renal Cell Cancer;   Stage IIA Prostate Cancer;   Stage IIB Prostate Cancer;   Stage III Prostate Cancer;   Stage III Renal Cell Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Procedure: Radical Cystectomy;   Biological: Recombinant EphB4-HSA Fusion Protein;   Procedure: Therapeutic Conventional Surgery
17 Not yet recruiting Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons
Condition: Prostate Cancer
Interventions: Radiation: Radiotherapy with protons;   Radiation: Radiotherapy with photons
18 Not yet recruiting Pivotal Study of MRI-guided Transurethral US Ablation to Treat Localized Prostate Cancer
Condition: Prostate Cancer
Intervention: Device: MRI-guided Transurethral Ultrasound Ablation
19 Not yet recruiting Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Genistein;   Drug: Placebo
20 Recruiting Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer
Condition: Adenocarcinoma of the Prostate
Interventions: Radiation: IGRT 45 Gy in 5 fractions of 9 Gy;   Procedure: Image-guided, volumetric intensity-modulated arc radiotherapy (IGRT-VMAT);   Device: Rectal balloon with air filling;   Device: Urethral catheter loaded with beacon transponders

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years